SGS Life Science Services - - BioPharm International


SGS Life Science Services

BioPharm International
Volume 19, Issue 12

Company Description

SGS is a verification testing, inspection, and certification company. SGS Life Science Services is a contract service organization providing clinical research services and quality control testing. We serve a variety of Life Science companies including pharmaceutical, biopharmaceutical, biotechnology and medical device manufacturers. SGS provides clinical trial management (Phase 1 to 4) and services encompassing bioequivalence studies, bioanalytical services, data management, biometrics and regulatory consultancy. Our quality control services (detailed below) complete our portfolio by offering analytical chemistry, microbiology, and toxicology tests that meet regulatory compliance.

Biopharmaceutical Techniques Supported

  • Cell Line Characterization
  • Host Cell Impurity Testing
  • Mycoplasma Testing
  • Protein Analysis

Markets Served

SGS operates a global network of quality control testing laboratories with facilities in the USA, Canada, Belgium, France, Germany, India, Hong Kong, China, South Korea, Taiwan, Thailand and Singapore.

Products and Services

  • Quality control testing of raw materials, APIs and finished products
  • Monograph testing (USP, EP, BP, JP)
  • Analytical method development and validation
  • Container testing
  • Environmental testing
  • Inspection services
  • Medical device testing
  • Microbiological testing
  • Safety testing (in vivo, in vitro)
  • Stability testing according to ICH guidelines or customer specifications
  • Toxicology
  • Water System Validation


In North America, SGS has facilities in Northbrook, IL, Fairfield, NJ, Spartanburg, SC, and Mississauga, ON. Our quality control laboratories operate according to the highest quality standards (cGMP, GLP, ISO 17025) and have been inspected by the FDA or local regulatory authorities.

75 Passaic Avenue
Fairfield NJ 07004



1,300 (USA)
43,000 (worldwide)


blog comments powered by Disqus



GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here